Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-25 @ 4:06 AM
NCT ID:
NCT05327920
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of moderate to severe active rheumatoid arthritis (RA) upon judgment of the treating physician.
* Upadacitinib prescribed in accordance with the applicable approved label and local regulatory and reimbursement policies and upadacitinib treatment was started within 1 week before the enrollment.
* Physician decision on participant treatment with upadacitinib must have been reached prior to and independently of recruitment in the study.
Exclusion Criteria:
* Participants who cannot be treated with upadacitinib as per SmPC or local prescription criteria.
* Prior treatment course with upadacitinib or the current upadacitinib treatment was started more than 1 week prior to enrollment.
* Participant currently participating in any interventional study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05327920
Study Brief:
Protocol Section:
NCT05327920